Leukemia

Minimal Residual Disease Testing’s Variability Across Cancer Types

February 26, 2025

Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and monitoring based on disease characteristics.

What to Expect With a Stem Cell Transplant for Leukemia

September 06, 2024

Dr. Partow Kebriaei explains what patients can expect before, during and after an allogeneic stem cell transplant to treat acute lymphoblastic leukemia.

Advancing CML Management Towards an Ideal Patient Journey

August 28, 2024

The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.

Ensuring Informed CML Care from Diagnosis Onward

August 21, 2024

Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.

CML Treatment: Scenarios that Necessitate Switching Therapy

August 21, 2024

Jorge E. Cortes, MD, details clinical scenarios that indicate a need to switch therapies for patients with chronic myeloid leukemia.

When CML Therapy Shifts: Collaborative Approaches to Treatment Changes

August 14, 2024

Claire Saxton shares insights on how physicians and caregivers can best assist patients with CML who have switched therapies.

Open Dialogue in CML Care: Setting Expectations, Managing Side Effects, and Optimizing Patient Quality of Life

August 14, 2024

A panel of experts on chronic myeloid leukemia discuss common patient concerns, adverse effect considerations, and best practices for setting clear expectations.

Starting CML Treatment: Collaborative Choices for Better Outcomes

August 07, 2024

Focusing on the initiation of treatment for newly diagnosed patients with CML, Jorge E. Cortes, MD, details important factors to consider when starting treatment and Claire Saxton discusses strategies that optimize communication when considering treatment options.

Empowering CML Caregivers: Strategies and Support Systems

August 07, 2024

Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients.

Sponsored DTC Video

October 11, 2023

Knowing MRD Status Can ‘Increase Chance of Cure’ in Blood Cancer

August 08, 2023

What Is CAR-T Cell Therapy, and What Can Patients With Cancer Expect?

September 16, 2022

Over the past five years, CAR-T cell therapy has improved outcomes for many patients with blood cancer. Here’s what patients need to know about the immune-based treatment.

The 'Flipside' of Tumor Lysis Syndrome Shows Efficacy in Leukemia, Lymphoma

August 11, 2022

Although tumor lysis syndrome may be dangerous and fatal if not treated early, experts note that it is a sign of successful treatment in patients with leukemia and lymphoma.

FDA OKs Continued Enrollment in Ongoing Blood Cancer Clinical Trials After Gilead Addresses Safety Concerns

April 15, 2022

Earlier in the year, clinical trials assessing magrolimab for myelodysplastic syndrome and acute myeloid leukemia were put on a partial clinical hold, but now the FDA said that they can start enrolling patients again.

New Treatments Lend a Positive Outlook to Patients With GVHD

February 28, 2022

There are now more drugs than ever to treat and prevent graft-versus-host disease in patients with blood cancer who receive a stem cell transplant.

Trial Initiated to Study Protein-Inhibiting Treatment Option for Patients With Acute Leukemia

February 17, 2022

A trial to examine BMF-219 in patients with relapsed or refractory acute leukemias has begun recruiting patients across multiple U.S. states.

Leukemia Risk Factors

October 11, 2018

Is there anything that we can do to lessen our child’s risk of developing this terrible disease? Let’s talk today about leukemia risk factors and its effect on kids